HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary emboli in patients receiving chemotherapy for non-Hodgkin's lymphoma.

Abstract
Combination chemotherapy has dramatically improved the prognosis of patients with intermediate and high grade histologic subtypes of non-Hodgkin's lymphomas. Treatment-related complications, however, are considerable, and a common problem encountered is respiratory distress or respiratory insufficiency. Usually these difficulties have been attributed to infectious etiologies or to chemotherapy-induced interstitial fibrosis, most often involving bleomycin. We describe five patients presenting with respiratory problems several weeks after the initiation of chemotherapy. These patients, who represent 3 percent of all patients treated with a single bleomycin-containing regimen for intermediate or high grade non-Hodgkin's lymphoma, were all initially thought to have chemotherapy-induced interstitial fibrosis but were found on subsequent evaluation to have pulmonary emboli. Of the three patients in whom pulmonary emboli were diagnosed antemortem, two had symptoms suggestive of pulmonary emboli and all were successfully treated and remained well and free of lymphoma for over 24 months. Two additional patients were diagnosed at autopsy. We suggest that pulmonary emboli may contribute significantly to the morbidity and mortality of patients undergoing chemotherapy for non-Hodgkin's lymphoma and recommend that patients presenting with respiratory difficulties be evaluated for pulmonary emboli.
AuthorsL D Glenn, J O Armitage, J C Goldsmith, S Sorensen, D Howe, D D Weisenberger
JournalChest (Chest) Vol. 94 Issue 3 Pg. 589-94 (Sep 1988) ISSN: 0012-3692 [Print] United States
PMID2457470 (Publication Type: Journal Article)
Chemical References
  • Phosphoramide Mustards
  • Bleomycin
  • Vinblastine
  • Doxorubicin
  • Cisplatin
  • Prednisone
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Bleomycin (administration & dosage, adverse effects)
  • Cisplatin (administration & dosage, adverse effects)
  • Diagnosis, Differential
  • Doxorubicin (administration & dosage, adverse effects)
  • Female
  • Humans
  • Lymphoma, Non-Hodgkin (drug therapy)
  • Male
  • Middle Aged
  • Phosphoramide Mustards (administration & dosage, adverse effects)
  • Prednisone (administration & dosage, adverse effects)
  • Pulmonary Embolism (chemically induced, diagnosis)
  • Pulmonary Fibrosis (diagnosis)
  • Vinblastine (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: